Triphenylarsine → 5(R)-isoxazol-3-yloxymethyl-3-(4-{8-tert-butyloxycarbonyl-8-azabicyclo[3.2.1]oct-2-ene-3-yl}-3-fluorophenyl)oxazolidin-2-one

HRID 1167504ノート

反応式

HRID 1167504 の反応式
C1([As](C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.[Cl-].[Li+].[O:22]1[CH:26]=[CH:25][C:24]([O:27][CH2:28][C@@H:29]2[O:33][C:32](=[O:34])[N:31]([C:35]3[CH:40]=[CH:39][C:38](I)=[C:37]([F:42])[CH:36]=3)[CH2:30]2)=[N:23]1.[C:43]([O:47][C:48]([N:50]1[CH:55]2[CH2:56][CH2:57][CH:51]1[CH:52]=[C:53]([Sn](C)(C)C)[CH2:54]2)=[O:49])([CH3:46])([CH3:45])[CH3:44].[F-].[K+]>CN(C=O)C.[Pd].[Pd].C(=CC(C=CC1C=CC=CC=1)=O)C1C=CC=CC=1.C(=CC(C=CC1C=CC=CC=1)=O)C1C=CC=CC=1.C(=CC(C=CC1C=CC=CC=1)=O)C1C=CC=CC=1>[O:22]1[CH:26]=[CH:25][C:24]([O:27][CH2:28][C@@H:29]2[O:33][C:32](=[O:34])[N:31]([C:35]3[CH:40]=[CH:39][C:38]([C:53]4[CH2:54][CH:55]5[N:50]([C:48]([O:47][C:43]([CH3:46])([CH3:45])[CH3:44])=[O:49])[CH:51]([CH2:57][CH2:56]5)[CH:52]=4)=[C:37]([F:42])[CH:36]=3)[CH2:30]2)=[N:23]1

参加物

8

反応物 5

HCID 11773TriphenylarsineHCID 433294Lithium ChlorideHCID 522689Potassium FluorideHCID 118590405(R)-isoxazol-3-yloxymethyl-3-(3-fluoro-4-iodophenyl)oxazolidin-2-oneHCID 22647946Tert-butyl 3-(trimethylstannyl)-8-azabicyclo[3.2.1]oct-2-ene-8-carboxylate

生成物 1

HCID 213566705(R)-isoxazol-3-yloxymethyl-3-(4-{8-tert-butyloxycarbonyl-8-azabicyclo[3.2.1]oct-2-ene-3-yl}-3-fluorophenyl)oxazolidin-2-one

試薬・触媒・溶媒 2

HCID 9832798Tris(dibenzylideneacetone) dipalladium触媒HCID 6228Dimethylformamide溶媒2 回

反応条件

温度
60 °C

実験手順

Tris(dibenzylideneacetone) dipalladium(0) (0.19 g, 0.208 mmol), triphenylarsine (0.13 g, 0.425 mmol) and lithium chloride (0.265 g, 6.31 mmol) were added to a stirred solution of 5(R)-isoxazol-3-yloxymethyl-3-(3-fluoro-4-iodophenyl)oxazolidin-2-one (prepared by analogy to reference Example 28) (0.85 g, 2.1 mmol) in degassed DMF (35 ml) under nitrogen. After 5 minutes, a solution of 8-tert-butyloxycarbonyl-3-trimethylstannyl-8-azabicyclo[3.2.1]oct-2-ene (GB 2298647; 0.78 g, 2.1 mmol) in DMF (4 ml) was added and the mixture was heated at 60° C. for 18 hours. A solution of 2M potassium fluoride (30 ml) was added and the mixture stirred for 40 minutes. Solvent was evaporated and the residue partitioned between water and EtOAc. The aqueous layer was extracted twice with EtOAc and the combined extracts dried (Na2SO4) and evaporated. The residue was purified by column chromatography, eluting with a gradient of dichloromethane-5% MeOH/dichloromethane to give 5(R)-isoxazol-3-yloxymethyl-3-(4-{8-tert-butyloxycarbonyl-8-azabicyclo[3.2.1]oct-2-ene-3-yl }-3-fluorophenyl)oxazolidin-2-one as an oil of 85% purity [hplc](0.97 g, 81%). MS: 486 (MH+).

後処理

  1. customSolvent was evaporated
  2. customthe residue partitioned between water and EtOAc
  3. extractionThe aqueous layer was extracted twice with EtOAc
  4. dry with materialthe combined extracts dried (Na2SO4)
  5. customevaporated
  6. customThe residue was purified by column chromatography
  7. washeluting with a gradient of dichloromethane-5% MeOH/dichloromethane

出典と根拠

ORDレコード
ord-9d111d41df3444abbc7ea6e0f0926420
出典データセット
uspto-grants-2003_09
特許番号
US06617339B1

反応ノート

読み込み中…